-
WEHI-539 Workflow for BCL-XL Apoptosis Studies
2026-08-15
WEHI-539 is a selective BCL-XL inhibitor for separating BCL-XL dependence from broader BCL-2 family effects. This practical guide covers formulation, apoptosis assays, MCL-1 interaction studies, cancer stem cell sensitization, and troubleshooting for reproducible workflows.
-
SPI1–Wnt5a Signaling in Intracranial Aneurysm
2026-08-15
A 2026 study identifies SPI1 as a functional driver of intracranial aneurysm formation and connects its activity to transcriptional suppression of Wnt5a, activation of Wnt/β-catenin signaling, and vascular smooth muscle cell phenotypic switching. Combining PDGF-BB-treated cells, chromatin immunoprecipitation, pathway inhibition, and an aneurysm mouse model, the work provides a mechanistic framework for interpreting SPI1 as more than an IA-associated marker.
-
Methicillin Sodium Salt for MSSA Research
2026-08-14
Methicillin sodium salt enables controlled modeling of MSSA susceptibility, cell-wall inhibition, and methicillin resistance. This guide pairs a practical dilution workflow with MSSA–MRSA comparison strategies, assay controls, and troubleshooting guidance for reproducible Staphylococcus aureus infection research.
-
MnTBAP Chloride in Mitochondrial Stress Models
2026-08-14
MnTBAP Chloride helps researchers connect mitochondrial superoxide scavenging with oxidative injury, inflammation, and stress-related phenotypes. This workflow-oriented guide shows how to use the compound in endothelial assays, preclinical inflammation models, and chronic-stress studies while avoiding common interpretation and handling errors.
-
BRCA1 Loss and T-Cell Exhaustion in Ovarian Cancer
2026-08-13
Beziaud and colleagues show that Brca1 deficiency, unlike Brca2 deficiency, can create an inflamed but functionally exhausted tumor microenvironment that prevents a dendritic-cell cancer vaccine from improving outcome. In the mouse ID8 model, combining vaccination with PARP inhibition and immune checkpoint blockade partially restored T-cell activity and promoted survival, providing a mechanistic framework for combination immunotherapy in BRCA1-mutated ovarian cancer.
-
Gepotidacin: From Mechanism to Assay Design
2026-08-13
Gepotidacin, also known as GSK2140944, connects an unconventional topoisomerase mechanism with a clinically meaningful uUTI assay strategy. This guide explains how to translate biochemical, microbiological, and clinical evidence into rigorous antibacterial research decisions.
-
Cyclic di-GMP Workflows for Biofilm and STING Research
2026-08-12
Cyclic di-GMP supports two complementary research directions: dissecting biofilm persistence and probing STING-driven immune activation. This practical guide translates its antitoxin mechanism into bacterial assays and its agonist activity into immune modulation research, with preparation, protocol, comparison, and troubleshooting guidance.
-
4-Hydroxytamoxifen: Protocol and QC Guide
2026-08-12
4-Hydroxytamoxifen is a DMSO-soluble estrogen receptor modulator for controlled cell, cardiac myocyte, and selected in vivo research workflows. Its limited solubility in water and ethanol makes it unsuitable for aqueous or ethanol-only protocols, while storage and vehicle controls are important for reproducibility.
-
Mitomycin C as a Precision Apoptosis Tool
2026-08-11
Mitomycin C is more than an antitumor antibiotic: it can serve as a calibrated DNA-damage perturbation for apoptosis signaling research. This article connects its replication-blocking activity with assay-design lessons from IgG1+ germinal-center B-cell selection.
-
Podophyllotoxin for Cell-Cycle and Autophagy Studies
2026-08-10
Podophyllotoxin provides a practical microtubule-based perturbation for dissecting mitotic arrest, apoptosis, and survival signaling in cancer models. This workflow uses the JXE-23 hepatocellular carcinoma study as a mechanistic comparator while emphasizing concentration control, autophagy-flux validation, and reproducible troubleshooting.
-
A40926 Production Tools in Nonomuraea
2026-08-09
Yushchuk and colleagues developed promoter-probe and regulatory engineering tools for the genetically recalcitrant glycopeptide producer Nonomuraea gerenzanensis. Their results show that strengthening pathway-specific positive regulation can increase A40926 production and provide a rational alternative to trial-and-error strain improvement.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Assay Design
2026-08-08
Learn how EZ Cap™ Human PTEN mRNA (ψUTP) supports delivery-aware cancer research, from Cap 1 and pseudouridine design to pathway-level validation. This guide translates nanoparticle-mediated PTEN restoration findings into practical assay decisions and controls.
-
MG-132: From Proteasome Stress to Translation
2026-08-07
MG-132, also known as Z-LLL-al, is more than a proteasome inhibitor: it is a controllable perturbation of proteostasis, redox balance, mitochondrial integrity, and cell fate. This thought-leadership guide shows translational researchers how to distinguish proteasome engagement from downstream apoptosis, design stronger cell cycle arrest studies, and interpret cancer research data without confusing reduced viability with cell killing.
-
Meropenem Trihydrate: Carbapenem Antibiotic in Resistance Re
2026-08-07
Meropenem trihydrate empowers researchers to dissect bacterial resistance mechanisms and drive rapid diagnostic advancements, especially in the context of carbapenemase-producing Enterobacterales. Its robust solubility and broad-spectrum activity enable reproducible, high-sensitivity workflows for antibiotic resistance studies and acute infection models.
-
Mouse Tissue Lysis Kit (K1038): Protocol and Workflow Guide
2026-08-06
The Mouse Tissue Lysis Kit (K1038) streamlines sample preparation for direct genotyping assays by rapidly lysing mouse tissues and enabling direct PCR. It is suitable for molecular biology research workflows and is not intended for diagnostic or clinical use.
454 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page